Literature DB >> 25200068

First Ebola treatment is approved by WHO.

Anne Gulland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25200068     DOI： 10.1136/bmj.g5539

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

Review 1.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

2.  Treatment of Ebola virus disease.

Authors:  Yazdan Yazdanpanah; Jose Ramon Arribas; Denis Malvy
Journal:  Intensive Care Med       Date:  2014-11-11       Impact factor: 17.440

3.  The cost of an Ebola case.

Authors:  Sarah M Bartsch; Katrin Gorham; Bruce Y Lee
Journal:  Pathog Glob Health       Date:  2015-01-11       Impact factor: 2.894

4.  Ebola virus protein VP40 binding to Sec24c for transport to the plasma membrane.

Authors:  Nisha Bhattarai; Elumalai Pavadai; Rudramani Pokhrel; Prabin Baral; Md Lokman Hossen; Robert V Stahelin; Prem P Chapagain; Bernard S Gerstman
Journal:  Proteins       Date:  2021-09-03

5.  Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics.

Authors:  Jeffrey R Kugelman; Mariano Sanchez-Lockhart; Kristian G Andersen; Stephen Gire; Daniel J Park; Rachel Sealfon; Aaron E Lin; Shirlee Wohl; Pardis C Sabeti; Jens H Kuhn; Gustavo F Palacios
Journal:  mBio       Date:  2015-01-20       Impact factor: 7.867

Review 6.  Ebola virus disease and the veterinary perspective.

Authors:  Semra Gumusova; Mustafa Sunbul; Hakan Leblebicioglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-05-28       Impact factor: 3.944

7.  Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries.

Authors:  Magdy El-Ekiaby; Mariángela Vargas; Makram Sayed; George Gorgy; Hadi Goubran; Mirjana Radosevic; Thierry Burnouf
Journal:  PLoS Negl Trop Dis       Date:  2015-02-26

8.  Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.

Authors:  Jason Long; Edward Wright; Eleonora Molesti; Nigel Temperton; Wendy Barclay
Journal:  F1000Res       Date:  2015-01-29

9.  Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.

Authors:  Tansy Edwards; Malcolm G Semple; Anja De Weggheleire; Yves Claeys; Maaike De Crop; Joris Menten; Raffaella Ravinetto; Sarah Temmerman; Lutgarde Lynen; Elhadj Ibrahima Bah; Peter G Smith; Johan van Griensven
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486

10.  Ebola Virus Infection: Overview and Update on Prevention and Treatment.

Authors:  Miguel J Martínez; Abdulbaset M Salim; Juan C Hurtado; Paul E Kilgore
Journal:  Infect Dis Ther       Date:  2015-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.